What We Do
Prinston Pharma is an integrated pharmaceutical company in the United States that develops, manufactures, and markets high-quality and affordable generic medicines. Headquartered in Somerset, New Jersey, Prinston Pharma boasts world-class capability in generic drug R&D, cGMP manufacturing, and Sales & Marketing. With years of transformation-upgrading and industrial restructuring, Prinston has established a complete supply chain of APIs and pharmaceutical products, along with large manufacturing bases globally.
Our highly experienced R&D team meets market needs through innovation, in order to bring quality products to the US market and to help patients reduce their medical costs. We have developed an extensive portfolio of products in therapeutic areas that include cardiovascular disease, CNS disease, viral disease, and oncology.
US manufacturing work is done through our subsidiary Prinston Lab, which is located in Charlotte, North Carolina. We have capability in the production of a variety of capsules and tablets. Moreover, this cGMP facility is licensed by the United States Drug Enforcement Agency (DEA) for handling of controlled substances including those in Schedules II, III, IV, and V.
